» Articles » PMID: 16254342

Laser-capture Microdissection: Refining Estimates of the Quantity and Distribution of Latent Herpes Simplex Virus 1 and Varicella-zoster Virus DNA in Human Trigeminal Ganglia at the Single-cell Level

Overview
Journal J Virol
Date 2005 Oct 29
PMID 16254342
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

There remains uncertainty and some controversy about the percentages and types of cells in human sensory nerve ganglia that harbor latent herpes simplex virus 1 (HSV-1) and varicella-zoster virus (VZV) DNA. We developed and validated laser-capture microdissection and real-time PCR (LCM/PCR) assays for the presence and copy numbers of HSV-1 gG and VZV gene 62 sequences in single cells recovered from sections of human trigeminal ganglia (TG) obtained at autopsy. Among 970 individual sensory neurons from five subjects, 2.0 to 10.5% were positive for HSV-1 DNA, with a median of 11.3 copies/positive cell, compared with 0.2 to 1.5% of neurons found to be positive by in situ hybridization (ISH) for HSV-1 latency-associated transcripts (LAT), the classical surrogate marker for HSV latency. This indicates a more pervasive latent HSV-1 infection of human TG neurons than originally thought. Combined ISH/LCM/PCR assays revealed that the majority of the latently infected neurons do not accumulate LAT to detectable levels. We detected VZV DNA in 1.0 to 6.9% of individual neurons from 10 subjects. Of the total 1,722 neurons tested, 4.1% were VZV DNA positive, with a median of 6.9 viral genomes/positive cell. After removal by LCM of all visible neurons on a slide, all surrounding nonneuronal cells were harvested and assayed: 21 copies of HSV-1 DNA were detected in approximately 5,200 nonneuronal cells, while nine VZV genomes were detected in approximately 14,200 nonneuronal cells. These data indicate that both HSV-1 and VZV DNAs persist in human TG primarily, if not exclusively, in a moderate percentage of neuronal cells.

Citing Articles

Repression of varicella zoster virus gene expression during quiescent infection in the absence of detectable histone deposition.

Wang J, Bruckner N, Weissmann S, Gunther T, Zhu S, Vogt C PLoS Pathog. 2025; 21(2):e1012367.

PMID: 39928684 PMC: 11838886. DOI: 10.1371/journal.ppat.1012367.


Lytic promoter activity during herpes simplex virus latency is dependent on genome location.

Singh N, Zachariah S, Phillips A, Tscharke D J Virol. 2024; 98(11):e0125824.

PMID: 39431845 PMC: 11575402. DOI: 10.1128/jvi.01258-24.


Reanalysis of single-cell RNA sequencing data does not support herpes simplex virus 1 latency in non-neuronal ganglionic cells in mice.

Ouwendijk W, Roychoudhury P, Cunningham A, Jerome K, Koelle D, Kinchington P J Virol. 2024; 98(4):e0185823.

PMID: 38445887 PMC: 11019907. DOI: 10.1128/jvi.01858-23.


The expression and function of HSV ICP47 and its promoter in mice.

Velusamy T, Singh N, Croft S, Smith S, Tscharke D J Virol. 2023; 97(11):e0110723.

PMID: 37902400 PMC: 10688380. DOI: 10.1128/jvi.01107-23.


The Intersection of Innate Immune Pathways with the Latent Herpes Simplex Virus Genome.

Cuddy S, Cliffe A J Virol. 2023; 97(5):e0135222.

PMID: 37129520 PMC: 10231182. DOI: 10.1128/jvi.01352-22.


References
1.
Croen K, Ostrove J, Dragovic L, Straus S . Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A. 1988; 85(24):9773-7. PMC: 282863. DOI: 10.1073/pnas.85.24.9773. View

2.
Ashley R, Militoni J, Lee F, Nahmias A, Corey L . Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988; 26(4):662-7. PMC: 266403. DOI: 10.1128/jcm.26.4.662-667.1988. View

3.
Burke R, Hartog K, Croen K, Ostrove J . Detection and characterization of latent HSV RNA by in situ and northern blot hybridization in guinea pigs. Virology. 1991; 181(2):793-7. DOI: 10.1016/0042-6822(91)90920-7. View

4.
Cook S, Paveloff M, Doucet J, Cottingham A, Sedarati F, Hill J . Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci. 1991; 32(5):1558-61. View

5.
Trousdale M, Steiner I, Spivack J, Deshmane S, Brown S, MacLean A . In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model. J Virol. 1991; 65(12):6989-93. PMC: 250813. DOI: 10.1128/JVI.65.12.6989-6993.1991. View